Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Repligen Corp RGEN

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:RGEN)

No current opinion is available.

Bullboard Posts (NDAQ:RGEN)

Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tue

BREAKING NEWS: $RGEN Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tuesday SessionRepligen Corporation (NASDAQ: RGEN) has...
whytestocks - 2 days ago

Repligen Reports Fourth Quarter and Full Year 2023 Financial

Breaking News: $RGEN Repligen Reports Fourth Quarter and Full Year 2023 Financial ResultsReports fourth quarter revenue of $156 million...
whytestocks - February 21, 2024

Healthcare Stocks to Watch

There is a wide array of offerings from innovative care to advanced digital technologies from every corner of the market assessing just...
SHFeatureArticl - February 28, 2020

settled a patent suit

settled a patent suit that it filed with the University of Michigan against Bristol-Myers Squibb . The deal entitles Repligen to an...
mart33 - April 10, 2008

Good Ole Boy''s

CoastalTrader - May 30, 2007

MARCH WATCH 2007

ABN BAY CVV ETG ESO GZZ HAT IRK LGR NCR PEM PDP PRD PGD ROK...
CoastalTrader - March 10, 2007